Addex Therapeutics Ltd. Rings the Closing Bell
ABOUT THIS EVENT
Addex Therapeutics Ltd. (Nasdaq: ADXN), a leading allosteric modulation-based drug discovery and development company, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Tim Dyer, CEO, rang the Closing Bell.